Washington
+919359902383
+919359902383
sedative-hypnotic

Eszopigard-3 mg Tablet Exporter from India | Bulk Eszopiclone Supply to Washington, London, Bangkok, Canberra, Singapore, & Kingston | Ernest Impex

In stockcod not available
Phone Number

+919359902383

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Washington D.C., DC, USA

Washington, United States, 20001

Description

Eszopigard-3 mg Tablets: High-Potency Non-Benzodiazepine Hypnotic for Global Institutional Supply Chains In-Depth Product Analysis & Clinical Profile Eszopigard-3 mg Tablet is a highly specialized oral sleep-induction medication engineered for targeted clinical intervention in severe sleep architectural disruptions. Each tablet contains exactly 3 mg of Eszopiclone USP, a highly pure non-benzodiazepine hypnotic agent belonging to the cyclopyrrolone chemical class, recognized worldwide as a therapeutic standard for complex sleep maintenance disorders. Clinical Indications & Therapeutic Scope Severe Sleep Maintenance Insomnia: Specifically formulated for patients who experience frequent, abnormal nighttime awakenings, helping them achieve a continuous, deep, and stable sleep cycle throughout the night. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Physiological Mechanism of Action Selective GABA-A Receptor Modulation: Eszopiclone functions as a highly selective positive allosteric modulator that binds to the gamma-aminobutyric acid- receptor complex. It targets specific receptor sub-units at a site distinct from traditional benzodiazepine molecules. Chloride Channel Amplification: By enhancing the affinity of the receptor for endogenous (the central nervous system's primary inhibitory neurotransmitter), it triggers a greater influx of chloride ions into the post-synaptic neurons. Neuronal Hyperpolarization and Sedation: This ion influx induces post-synaptic cellular hyperpolarization, slowing down overactive neuronal firing across the brain's arousal centers. This calms the central nervous system, promotes muscle relaxation, and establishes the ideal physiological state for deep, restorative sleep. Technical Storage, Stability, and Handling Protocols Temperature Restrictions: Store Eszopigard-3 mg Tablets at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Moisture & Ultraviolet Mitigation: Keep the tablets sealed within their original factory blister packaging or high-barrier commercial containers. Protect the cargo from high humidity, steam, or direct exposure to sunlight. Inventory Safety: Store in a locked, secure pharmaceutical repository suitable for controlled prescription medications, completely separated from standard retail products and out of reach of minors. Comprehensive Clinical Side Effects & Tolerability Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Gastrointestinal and Mucosal Effects: Potential reactions include distinct dry mouth (xerostomia), mild nausea, dyspepsia, and a minor increase in susceptibility to mild respiratory tract infections due to secondary mucosal drying. International Regulatory Documentation & Quality Portfolios Certificate of Analysis (COA): Comprehensive laboratory validation proving exact 3 mg active ingredient concentration per unit, batch uniformity, dissolution rates, and absolute chemical purity. Certificate of Origin (COO): Officially stamped documentation verifying that the formulation was produced in an authorized, certified Indian pharmaceutical manufacturing facility. Customs-Ready Trade Manifesting: Detailed packing slips, commercial invoices, dangerous goods or restricted substance transport declarations, and correct Harmonized System (HS) import codes to ensure efficient processing through international border networks. PRESCRIPTION MEDICINE IS YES Clinical Disclaimer: This product summary is compiled strictly for international wholesale distribution networks, and digital optimization indexing. Eszopigard-3 mg Tablets (Eszopiclone) are highly potent, restricted prescription medications that carry a risk of misuse and dependency. This drug must be administered exclusively under the direct guidance and clinical evaluation of a licensed physician or psychiatrist. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Eszopigard-3 mg Tablets: High-Potency Non-Benzodiazepine Hypnotic for Global Institutional Supply Chains In-Depth Product Analysis & Clinical Profile Eszopigard-3 mg Tablet is a highly specialized oral sleep-induction medication engineered for targeted clinical intervention in severe sleep architectural disruptions. Each tablet contains exactly 3 mg of Eszopiclone USP, a highly pure non-benzodiazepine hypnotic agent belonging to the cyclopyrrolone chemical class, recognized worldwide as a therapeutic standard for complex sleep maintenance disorders. Clinical Indications & Therapeutic Scope Severe Sleep Maintenance Insomnia: Specifically formulated for patients who experience frequent, abnormal nighttime awakenings, helping them achieve a continuous, deep, and stable sleep cycle throughout the night. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Physiological Mechanism of Action Selective GABA-A Receptor Modulation: Eszopiclone functions as a highly selective positive allosteric modulator that binds to the gamma-aminobutyric acid- receptor complex. It targets specific receptor sub-units at a site distinct from traditional benzodiazepine molecules. Chloride Channel Amplification: By enhancing the affinity of the receptor for endogenous (the central nervous system's primary inhibitory neurotransmitter), it triggers a greater influx of chloride ions into the post-synaptic neurons. Neuronal Hyperpolarization and Sedation: This ion influx induces post-synaptic cellular hyperpolarization, slowing down overactive neuronal firing across the brain's arousal centers. This calms the central nervous system, promotes muscle relaxation, and establishes the ideal physiological state for deep, restorative sleep. Technical Storage, Stability, and Handling Protocols Temperature Restrictions: Store Eszopigard-3 mg Tablets at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Moisture & Ultraviolet Mitigation: Keep the tablets sealed within their original factory blister packaging or high-barrier commercial containers. Protect the cargo from high humidity, steam, or direct exposure to sunlight. Inventory Safety: Store in a locked, secure pharmaceutical repository suitable for controlled prescription medications, completely separated from standard retail products and out of reach of minors. Comprehensive Clinical Side Effects & Tolerability Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Gastrointestinal and Mucosal Effects: Potential reactions include distinct dry mouth (xerostomia), mild nausea, dyspepsia, and a minor increase in susceptibility to mild respiratory tract infections due to secondary mucosal drying. International Regulatory Documentation & Quality Portfolios Certificate of Analysis (COA): Comprehensive laboratory validation proving exact 3 mg active ingredient concentration per unit, batch uniformity, dissolution rates, and absolute chemical purity. Certificate of Origin (COO): Officially stamped documentation verifying that the formulation was produced in an authorized, certified Indian pharmaceutical manufacturing facility. Customs-Ready Trade Manifesting: Detailed packing slips, commercial invoices, dangerous goods or restricted substance transport declarations, and correct Harmonized System (HS) import codes to ensure efficient processing through international border networks. PRESCRIPTION MEDICINE IS YES Clinical Disclaimer: This product summary is compiled strictly for international wholesale distribution networks, and digital optimization indexing. Eszopigard-3 mg Tablets (Eszopiclone) are highly potent, restricted prescription medications that carry a risk of misuse and dependency. This drug must be administered exclusively under the direct guidance and clinical evaluation of a licensed physician or psychiatrist. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Zopfresh-E 6 mg Tablets: Advanced Hypnotic & Sleep Maintenance Therapy for Global Supply Chains Detailed Product Overview & Clinical Profile Zopfresh-E 6 mg Tablet is a highly specialized oral sedative-hypnotic formulation engineered for the targeted management of severe sleep architectural disruptions. Each film-coated tablet delivers a precise 6mg dose of Eszopiclone, a highly pure non-benzodiazepine hypnotic agent that has become a global standard in clinical sleep medicine. Clinical Indications & Therapeutic Scope Sleep Onset Insomnia: Indicated for patients who experience extreme difficulty initiating sleep, helping to significantly decrease sleep latency (the time it takes to fall asleep). Sleep Maintenance Insomnia: Formulated to reduce frequent, abnormal nighttime awakenings, ensuring a continuous and deeper sleep cycle throughout the night. Transient and Chronic Insomnia Management: Used in short-term clinical protocols to restore standard circadian rhythms disrupted by acute environmental stress, psychological fatigue, or chronic neurological imbalances. Physiological Mechanism of Action Central Nervous System Sedation: This electrical stabilization dampens overactive neuronal firing across the brain's arousal centers, naturally calming the central nervous system to induce rapid relaxation, accelerate sleep onset, and promote prolonged sleep maintenance. GABA-A Receptor Modulation: Eszopiclone functions as a non-benzodiazepine cyclic agent that binds selectively to the gamma-aminobutyric acid receptor complex at a site distinct from traditional benzodiazepines. Amplified Hyperpolarization: By acting as a positive allosteric modulator, it enhances the inhibitory actions of endogenous This triggers an influx of chloride ions into the post-synaptic neurons, resulting in cellular hyperpolarization. Strict Storage, Stability, and Handling Protocols Environmental Controls: Store Zopfresh-E 6mg Tablets strictly within a controlled room temperature range between 15°C to 30°C (59°F to 86°F). Moisture and Light Mitigation: Keep the tablets sealed within their original moisture-resistant blister packs or factory-sealed containers. Protect the stock from high ambient humidity, steam, and prolonged exposure to direct sunlight. Dispensing Safety: Store securely in an independent, locked storage location appropriate for controlled prescription medications, completely out of reach of children and unauthorized individuals. Clinical Side Effects & Tolerability Profile Taste Disturbances: A very common and distinct side effect is a persistent unpleasant, bitter, or metallic taste in the mouth (dysgeusia) upon waking. Central Nervous System Residual Effects: Patients may experience daytime drowsiness, mild dizziness, headaches, lightheadedness, or a feeling of a “hangover“ effect, particularly if they do not dedicate a full 7 to 8 hours to sleep after administration. Gastrointestinal and Systemic Distress: Potential side effects include dry mouth (xerostomia), mild nausea, dyspepsia, and occasional episodes of viral infections or colds due to transient immune shifts. Documentation & International Customs Compliance Certificate of Analysis (COA): Verifying independent laboratory assay testing, confirming precise 6mg Eszopiclone chemical potency, mass uniformity, and zero contamination. Certificate of Origin (COO): Officially validating genuine production and export compliance within certified Indian pharmaceutical manufacturing ecosystems. Customs-Validated Shipping Manifests: Providing precise packing lists, transparent commercial invoices, proper dangerous goods or controlled-substance shipping documentation, and correct Harmonized System (HS) codes tailored for smooth import processing. PRESCRIPTION MEDICINE IS YES Clinical Disclaimer: This comprehensive product profile is prepared for international wholesale distribution networks, and digital optimization indexing. Zopfresh-E 6 mg Tablet (Eszopiclone) is a highly potent, restricted prescription medication that can be habit-forming. It must be administered exclusively under the direct guidance and evaluation of a licensed physician or psychiatrist. It is strictly contraindicated for individuals with a history of complex sleep behaviors, severe respiratory depression, or advanced hepatic impairment. Patients must secure a dedicated 7 to 8 hours of uninterrupted sleep after consumption and must absolutely avoid alcohol or concurrent central nervous system depressants, 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
Nutritional Supplement

Numicob Injection Plus: Advanced Neurotrophic and High-Potency Vitamin B-Complex Therapy for Global Supply Chains Are you seeking a reliable, high-volume Numicob Injection Plus exporter from India to optimize your specialized medical and neurological supply chains? Ernest Impex, operating as the global trade arm of the Group of Ernest Pharmaceutical Pvt. Ltd., serves as a premier international supply partner, bulk medicine wholesaler, and expert pharmaceutical drop shipper. We maintain verified global logistics channels to safely deliver institutional neurotrophic and vitamin inventory to licensed hospital pharmacies, clinical care programs, and specialist distributors in Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica). Comprehensive Product Matrix: Technical & Clinical Specifications Product Name: Numicob Injection Plus (Also referenced as Numicob Plus Injection) Active Ingredients / Salt Composition:• Methylcobalamin (Mecobalamin): • Pyridoxine Hydrochloride (Vitamin B6) • Thiamine Hydrochloride (Vitamin B1) • Nicotinamide (Niacinamide / Vitamin B3) • D-Panthenol (Vitamin B5 derivative) Therapeutic Class Neurotrophic Vitamin B-Complex Combination / Nutritional Supplement Dosage Form & Route Sterile Aqueous Solution for Intramuscular (IM) or slow Intravenous (IV) Injection. Prescription Status: PRESCRIPTION MEDICINE IS YES Primary Clinical Indications: Indicated for the comprehensive management of severe nutritional deficiencies, peripheral neuropathies (such as diabetic or alcoholic neuropathy), megaloblastic anemia caused by Vitamin B12 deficiency, structural nerve damage, and chronic fatigue syndromes where rapid physiological replenishment is critical. Mechanisms of Action (MOA): 1. Myelin Sheath Regeneration: Methylcobalamin, an active coenzyme form of B12, donates methyl groups to facilitate the synthesis of lecithin and myelin lipids, repairing damaged peripheral nerves. 2. Cellular Energy Production: Thiamine and Nicotinamideact as vital coenzymes in carbohydrate metabolism and the Krebs cycle, converting nutrients into cellular adenosine triphosphate 3. Neurotransmitter Synthesis: Pyridoxineplays an essential role in amino acid metabolism and the biosynthesis of vital neurotransmitters like serotonin, dopamine, and gamma-aminobutyric acid Storage & Stability Protocols: Store the ampoules below 30°C (86°F) in a dry environment. Protect carefully from high humidity, structural freezing, and prolonged exposure to direct sunlight. Keep the vials or ampoules inside their original outer carton until the exact moment of clinical administration. Keep safely out of reach of children. Potential Side Effects: • Local Reactions: Transient pain, erythema (redness), mild swelling, or burning sensations at the site of intramuscular injection. • Gastrointestinal Effects: Mild nausea, vomiting, transient diarrhea, or stomach discomfort as the body adjusts. • Neurological Feedback: Very rarely, high doses of Pyridoxine can induce mild, reversible sensory neuropathies over prolonged unmonitored cycles. International Regulatory Trade Documentation 1. Certificate of Analysis (CoA): Detailed batch assessment verifying the exact milligram and microgram potencies of the combined B-vitamins, sterility indices, and chemical purity tolerances. 2. Certificate of Origin (CoO): Documents legitimate formulation origin within validated, certified Indian production lines. 3. Customs-Ready Packing List & Manifest: Clean commercial invoicing, batch serialization tracking, explicit expiry dating, and correct Harmonized System (HS) codes for smooth international clearance. Disclaimer: This product profile is compiled strictly for B2B procurement, wholesale trade networks, and international search engine optimization. Numicob Injection Plus is a highly concentrated prescription vitamin and neurotrophic compound. It must be administered exclusively by or under the direct supervision of a licensed healthcare professional (doctor or nurse); self-injection is strictly discouraged. Patients with pre-existing conditions like Leber's disease, severe renal insufficiency, or hepatic disorders must seek thorough medical valuation before use. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383